Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics的股票在公司公佈對慢性咳嗽II期CORAL試驗患者治療的積極結果後上漲。
Trevi Therapeutics Shares Are Trading Higher After the Company Announced Positive Outcomes for the Treatment of Patients From Its Chronic Cough Phase 2b CORAL Trial.
Trevi Therapeutics的股票在公司公佈對慢性咳嗽II期CORAL試驗患者治療的積極結果後上漲。
資訊熱榜
更新時間